Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: Biotechnology

HEALTH-CORONAVIRUS/BRITAIN-NOVOVAX
RTX8QZ20
January 29, 2021
A man walks his dog past the Fujifilm Diosynth Biotechnologies's facilities where they produce the coronavirus...
Stockton-On-Tees, United Kingdom
A man walks his dog past the Fujifilm Diosynth Biotechnologies's facilities, in Stockton-on-Tees
A man walks his dog past the Fujifilm Diosynth Biotechnologies's facilities where they produce the coronavirus disease (COVID-19) Novavax vaccine, in Stockton-on-Tees, Britain January 29, 2021. REUTERS/Lee Smith
HEALTH-CORONAVIRUS/BRITAIN-NOVOVAX
RTX8QYTW
January 29, 2021
A general view of the Fujifilm Diosynth Biotechnologies's facilities where they produce the coronavirus...
Stockton-On-Tees, United Kingdom
A general view of the Fujifilm Diosynth Biotechnologies's facilities, in Stockton-on-Tees
A general view of the Fujifilm Diosynth Biotechnologies's facilities where they produce the coronavirus disease (COVID-19) Novavax vaccine, in Stockton-on-Tees, Britain January 29, 2021. REUTERS/Lee Smith
HEALTH-CORONAVIRUS/BRITAIN-NOVOVAX
RTX8QYTV
January 29, 2021
A general view of the Fujifilm Diosynth Biotechnologies's facilities where they produce the coronavirus...
Stockton-On-Tees, United Kingdom
A general view of the Fujifilm Diosynth Biotechnologies's facilities, in Stockton-on-Tees
A general view of the Fujifilm Diosynth Biotechnologies's facilities where they produce the coronavirus disease (COVID-19) Novavax vaccine, in Stockton-on-Tees, Britain January 29, 2021. REUTERS/Lee Smith
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTX8E1XJ
December 05, 2020
A specialist works during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the...
Saint Petersburg, Russia
Production of Gam-COVID-Vac vaccine against the coronavirus disease in Saint Petersburg
A specialist works during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the coronavirus disease (COVID-19) at a facility of BIOCAD biotechnology company in Saint Petersburg, Russia December 4, 2020. Picture taken December 4, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTX8E1XI
December 05, 2020
A specialist works during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the...
Saint Petersburg, Russia
Production of Gam-COVID-Vac vaccine against the coronavirus disease in Saint Petersburg
A specialist works during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the coronavirus disease (COVID-19) at a facility of BIOCAD biotechnology company in Saint Petersburg, Russia December 4, 2020. Picture taken December 4, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTX8E1XA
December 05, 2020
A view shows vials during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the...
Saint Petersburg, Russia
Production of Gam-COVID-Vac vaccine against the coronavirus disease in Saint Petersburg
A view shows vials during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the coronavirus disease (COVID-19) at a facility of BIOCAD biotechnology company in Saint Petersburg, Russia December 4, 2020. Picture taken December 4, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTX8E1XD
December 05, 2020
A specialist works during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the...
Saint Petersburg, Russia
Production of Gam-COVID-Vac vaccine against the coronavirus disease in Saint Petersburg
A specialist works during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the coronavirus disease (COVID-19) at a facility of BIOCAD biotechnology company in Saint Petersburg, Russia December 4, 2020. Picture taken December 4, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTX8E1XB
December 05, 2020
A view shows boxes containing vials with Gam-COVID-Vac, also known as Sputnik-V, vaccine against the...
Saint Petersburg, Russia
Production of Gam-COVID-Vac vaccine against the coronavirus disease in Saint Petersburg
A view shows boxes containing vials with Gam-COVID-Vac, also known as Sputnik-V, vaccine against the coronavirus disease (COVID-19) at a production facility of BIOCAD biotechnology company in Saint Petersburg, Russia December 4, 2020. Picture taken December 4, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTX8E1XC
December 05, 2020
A view shows vials during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the...
Saint Petersburg, Russia
Production of Gam-COVID-Vac vaccine against the coronavirus disease in Saint Petersburg
A view shows vials during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the coronavirus disease (COVID-19) at a facility of BIOCAD biotechnology company in Saint Petersburg, Russia December 4, 2020. Picture taken December 4, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTX8E1X6
December 05, 2020
A view shows boxes containing vials with Gam-COVID-Vac, also known as Sputnik-V, vaccine against the...
Saint Petersburg, Russia
Production of Gam-COVID-Vac vaccine against the coronavirus disease in Saint Petersburg
A view shows boxes containing vials with Gam-COVID-Vac, also known as Sputnik-V, vaccine against the coronavirus disease (COVID-19) at a production facility of BIOCAD biotechnology company in Saint Petersburg, Russia December 4, 2020. Picture taken December 4, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTX8E1X3
December 05, 2020
A view shows vials during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the...
Saint Petersburg, Russia
Production of Gam-COVID-Vac vaccine against the coronavirus disease in Saint Petersburg
A view shows vials during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the coronavirus disease (COVID-19) at a facility of BIOCAD biotechnology company in Saint Petersburg, Russia December 4, 2020. Picture taken December 4, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTX8E1WZ
December 05, 2020
A view shows boxes during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the...
Saint Petersburg, Russia
Production of Gam-COVID-Vac vaccine against the coronavirus disease in Saint Petersburg
A view shows boxes during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the coronavirus disease (COVID-19) at a facility of BIOCAD biotechnology company in Saint Petersburg, Russia December 4, 2020. Picture taken December 4, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTX8E1WY
December 05, 2020
A view shows vials during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the...
Saint Petersburg, Russia
Production of Gam-COVID-Vac vaccine against the coronavirus disease in Saint Petersburg
A view shows vials during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the coronavirus disease (COVID-19) at a facility of BIOCAD biotechnology company in Saint Petersburg, Russia December 4, 2020. Picture taken December 4, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTX8E1WX
December 05, 2020
Specialists work during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the...
Saint Petersburg, Russia
Production of Gam-COVID-Vac vaccine against the coronavirus disease in Saint Petersburg
Specialists work during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the coronavirus disease (COVID-19) at a facility of BIOCAD biotechnology company in Saint Petersburg, Russia December 4, 2020. Picture taken December 4, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTX8E1WW
December 05, 2020
A specialist works during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the...
Saint Petersburg, Russia
Production of Gam-COVID-Vac vaccine against the coronavirus disease in Saint Petersburg
A specialist works during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the coronavirus disease (COVID-19) at a facility of BIOCAD biotechnology company in Saint Petersburg, Russia December 4, 2020. Picture taken December 4, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTX8E1WS
December 05, 2020
A view shows vials during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the...
Saint Petersburg, Russia
Production of Gam-COVID-Vac vaccine against the coronavirus disease in Saint Petersburg
A view shows vials during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the coronavirus disease (COVID-19) at a facility of BIOCAD biotechnology company in Saint Petersburg, Russia December 4, 2020. Picture taken December 4, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTX8E1WR
December 05, 2020
A view shows boxes during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the...
Saint Petersburg, Russia
Production of Gam-COVID-Vac vaccine against the coronavirus disease in Saint Petersburg
A view shows boxes during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the coronavirus disease (COVID-19) at a facility of BIOCAD biotechnology company in Saint Petersburg, Russia December 4, 2020. Picture taken December 4, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTX8E1WQ
December 05, 2020
Specialists work during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the...
Saint Petersburg, Russia
Production of Gam-COVID-Vac vaccine against the coronavirus disease in Saint Petersburg
Specialists work during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the coronavirus disease (COVID-19) at a facility of BIOCAD biotechnology company in Saint Petersburg, Russia December 4, 2020. Picture taken December 4, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTX8E1WP
December 05, 2020
A view shows vials during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the...
Saint Petersburg, Russia
Production of Gam-COVID-Vac vaccine against the coronavirus disease in Saint Petersburg
A view shows vials during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the coronavirus disease (COVID-19) at a facility of BIOCAD biotechnology company in Saint Petersburg, Russia December 4, 2020. Picture taken December 4, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTX8E1WJ
December 05, 2020
A specialist holds vials during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against...
Saint Petersburg, Russia
Production of Gam-COVID-Vac vaccine against the coronavirus disease in Saint Petersburg
A specialist holds vials during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the coronavirus disease (COVID-19) at a facility of BIOCAD biotechnology company in Saint Petersburg, Russia December 4, 2020. Picture taken December 4, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTX8E1WH
December 05, 2020
A specialist demonstrates a vial containing Gam-COVID-Vac, also known as Sputnik-V, vaccine against the...
Saint Petersburg, Russia
Production of Gam-COVID-Vac vaccine against the coronavirus disease in Saint Petersburg
A specialist demonstrates a vial containing Gam-COVID-Vac, also known as Sputnik-V, vaccine against the coronavirus disease (COVID-19) at a production facility of BIOCAD biotechnology company in Saint Petersburg, Russia December 4, 2020. Picture taken December 4, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTX8E1WK
December 05, 2020
A specialist works during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the...
Saint Petersburg, Russia
Production of Gam-COVID-Vac vaccine against the coronavirus disease in Saint Petersburg
A specialist works during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the coronavirus disease (COVID-19) at a facility of BIOCAD biotechnology company in Saint Petersburg, Russia December 4, 2020. Picture taken December 4, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTX8E1WI
December 05, 2020
A view shows boxes containing vials with Gam-COVID-Vac, also known as Sputnik-V, vaccine against the...
Saint Petersburg, Russia
Production of Gam-COVID-Vac vaccine against the coronavirus disease in Saint Petersburg
A view shows boxes containing vials with Gam-COVID-Vac, also known as Sputnik-V, vaccine against the coronavirus disease (COVID-19) at a production facility of BIOCAD biotechnology company in Saint Petersburg, Russia December 4, 2020. Picture taken December 4, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTX8E1W8
December 05, 2020
A view shows vials during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the...
Saint Petersburg, Russia
Production of Gam-COVID-Vac vaccine against the coronavirus disease in Saint Petersburg
A view shows vials during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the coronavirus disease (COVID-19) at a facility of BIOCAD biotechnology company in Saint Petersburg, Russia December 4, 2020. Picture taken December 4, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/USA-TRUMP
RTX7ZF64
October 02, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrisville, North Carolina, U.S., July 27, 2020. Picture taken July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA-TRUMP
RTX7ZF63
October 02, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrisville, North Carolina, U.S., July 27, 2020. Picture taken July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA-TRUMP
RTX7ZF61
October 02, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrisville, North Carolina, U.S., July 27, 2020. Picture taken July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA-TRUMP
RTX7ZF49
October 02, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrisville, North Carolina, U.S., July 27, 2020. Picture taken July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA-TRUMP
RTX7ZF48
October 02, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrisville, North Carolina, U.S., July 27, 2020. Picture taken July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA-TRUMP
RTX7ZF47
October 02, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrisville, North Carolina, U.S., July 27, 2020. Picture taken July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/ARGENTINA-VACCINE
RTX7PFSQ
August 13, 2020
A laboratory technician of biotechnology company mAbxience is seen working, amid the outbreak of the...
Outbreak of the coronavirus disease (COVID-19) in Buenos Aires
A laboratory technician of biotechnology company mAbxience is seen working, amid the outbreak of the coronavirus disease (COVID-19), in Buenos Aires, Argentina August 13, 2020. REUTERS/Agustin Marcarian
HEALTH-CORONAVIRUS/ARGENTINA-VACCINE
RTX7PFSS
August 13, 2020
The logo of biotechnology company mAbxience is seen on the facade of its building, amid the outbreak...
Outbreak of the coronavirus disease (COVID-19) in Buenos Aires
The logo of biotechnology company mAbxience is seen on the facade of its building, amid the outbreak of the coronavirus disease (COVID-19), in Buenos Aires, Argentina August 13, 2020. REUTERS/Agustin Marcarian
HEALTH-CORONAVIRUS/ARGENTINA-VACCINE
RTX7PFST
August 13, 2020
The logo of biotechnology company mAbxience is seen on the facade of its building, amid the outbreak...
Outbreak of the coronavirus disease (COVID-19) in Buenos Aires
The logo of biotechnology company mAbxience is seen on the facade of its building, amid the outbreak of the coronavirus disease (COVID-19), in Buenos Aires, Argentina August 13, 2020. REUTERS/Agustin Marcarian
HEALTH-CORONAVIRUS/ARGENTINA-VACCINE
RTX7PFSR
August 13, 2020
Laboratory technicians of biotechnology company mAbxience are seen as they work, amid the outbreak of...
Outbreak of the coronavirus disease (COVID-19) in Buenos Aires
Laboratory technicians of biotechnology company mAbxience are seen as they work, amid the outbreak of the coronavirus disease (COVID-19), in Buenos Aires, Argentina August 13, 2020. REUTERS/Agustin Marcarian
MOLECULAR PARTNERS-SWISS/
RTX7OXO9
August 11, 2020
Marcel Walser, Director Lead Generation of Swiss biotechnology company Molecular Partners displays a...
SCHLIEREN, Switzerland
Marcel Walser, Director Lead Generation of Swiss biotechnology company Molecular Partners displays a...
Marcel Walser, Director Lead Generation of Swiss biotechnology company Molecular Partners displays a petri dish containing bacterial colonies in a laboratory at the company's headquarters in Schlieren, Switzerland August 11, 2020. REUTERS/Arnd Wiegmann
MOLECULAR PARTNERS-SWISS/
RTX7OXNW
August 11, 2020
An employee of Swiss biotechnology company Molecular Partners controls a colony picker robot in a laboratory...
SCHLIEREN, Switzerland
An employee of Swiss biotechnology company Molecular Partners controls a colony picker robot in a laboratory...
An employee of Swiss biotechnology company Molecular Partners controls a colony picker robot in a laboratory at the company's headquarters in Schlieren, Switzerland August 11, 2020. REUTERS/Arnd Wiegmann
MOLECULAR PARTNERS-SWISS/
RTX7OXNY
August 11, 2020
An employee of Swiss biotechnology company Molecular Partners takes samples out of a colony picker robot...
SCHLIEREN, Switzerland
An employee of Swiss biotechnology company Molecular Partners takes samples out of a colony picker robot...
An employee of Swiss biotechnology company Molecular Partners takes samples out of a colony picker robot in a laboratory at the company's headquarters in Schlieren, Switzerland August 11, 2020. REUTERS/Arnd Wiegmann
MOLECULAR PARTNERS-SWISS/
RTX7OXNX
August 11, 2020
An employee of Swiss biotechnology company Molecular Partners controls a colony picker robot in a laboratory...
SCHLIEREN, Switzerland
An employee of Swiss biotechnology company Molecular Partners controls a colony picker robot in a laboratory...
An employee of Swiss biotechnology company Molecular Partners controls a colony picker robot in a laboratory at the company's headquarters in Schlieren, Switzerland August 11, 2020. REUTERS/Arnd Wiegmann
MOLECULAR PARTNERS-SWISS/
RTX7OXMP
August 11, 2020
Marcel Walser, Director Lead Generation of Swiss biotechnology company Molecular Partners works in a...
SCHLIEREN, Switzerland
Marcel Walser, Director Lead Generation of Swiss biotechnology company Molecular Partners works in a...
Marcel Walser, Director Lead Generation of Swiss biotechnology company Molecular Partners works in a laboratory at the company's headquarters in Schlieren, Switzerland August 11, 2020. REUTERS/Arnd Wiegmann
MOLECULAR PARTNERS-SWISS/
RTX7OXMN
August 11, 2020
Marcel Walser, Director Lead Generation of Swiss biotechnology company Molecular Partners works in a...
SCHLIEREN, Switzerland
Marcel Walser, Director Lead Generation of Swiss biotechnology company Molecular Partners works in a...
Marcel Walser, Director Lead Generation of Swiss biotechnology company Molecular Partners works in a laboratory at the company's headquarters in Schlieren, Switzerland August 11, 2020. REUTERS/Arnd Wiegmann
MOLECULAR PARTNERS-SWISS/
RTX7OXMF
August 11, 2020
CEO Patrick Amstutz of Swiss biotechnology company Molecular Partners poses in front of the company's...
SCHLIEREN, Switzerland
CEO Patrick Amstutz of Swiss biotechnology company Molecular Partners poses in Schlieren
CEO Patrick Amstutz of Swiss biotechnology company Molecular Partners poses in front of the company's logo in Schlieren, Switzerland August 11, 2020. REUTERS/Arnd Wiegmann
MOLECULAR PARTNERS-SWISS/
RTX7OXMD
August 11, 2020
CEO Patrick Amstutz of Swiss biotechnology company Molecular Partners poses in front of the company's...
SCHLIEREN, Switzerland
CEO Patrick Amstutz of Swiss biotechnology company Molecular Partners poses in Schlieren
CEO Patrick Amstutz of Swiss biotechnology company Molecular Partners poses in front of the company's logo in Schlieren, Switzerland August 11, 2020. REUTERS/Arnd Wiegmann
MOLECULAR PARTNERS-SWISS/
RTX7OXM1
August 11, 2020
CEO Patrick Amstutz of Swiss biotechnology company Molecular Partners poses in front of the company's...
SCHLIEREN, Switzerland
CEO Patrick Amstutz of Swiss biotechnology company Molecular Partners poses in Schlieren
CEO Patrick Amstutz of Swiss biotechnology company Molecular Partners poses in front of the company's logo in Schlieren, Switzerland August 11, 2020. REUTERS/Arnd Wiegmann
MOLECULAR PARTNERS-SWISS/
RTX7OXLS
August 11, 2020
The logo of Swiss biotechnology company Molecular Partners is seen at the company's headquarters in Schlieren,...
SCHLIEREN, Switzerland
Logo of Swiss biotechnology company Molecular Partners is seen in Schlieren
The logo of Swiss biotechnology company Molecular Partners is seen at the company's headquarters in Schlieren, Switzerland August 11, 2020. REUTERS/Arnd Wiegmann
HEALTH-CORONAVIRUS/USA
RTX7M5CL
July 27, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M5CK
July 27, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate Novavax are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M5A2
July 27, 2020
U.S. President Donald Trump faces a staff member during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump faces a staff member during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for the potential coronavirus disease (COVID-19) vaccine candidate Novavax are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M58S
July 27, 2020
U.S. President Donald Trump faces a staff member during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump faces a staff member during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for the potential coronavirus disease (COVID-19) vaccine candidate Novavax are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M58J
July 27, 2020
U.S. President Donald Trump faces a staff member during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump faces a staff member during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for the potential coronavirus disease (COVID-19) vaccine candidate Novavax are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M57Q
July 27, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate Novavax are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria TPX IMAGES OF THE DAY
HEALTH-CORONAVIRUS/USA
RTX7M579
July 27, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate Novavax are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M56X
July 27, 2020
U.S. President Donald Trump gestures during a tour of the Fujifilm Diosynth Biotechnologies' Innovation...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump gestures during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate Novavax are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M569
July 27, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate Novavax are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M561
July 27, 2020
U.S. President Donald Trump gestures during a tour of the Fujifilm Diosynth Biotechnologies' Innovation...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump gestures during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate Novavax are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M549
July 27, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M53Y
July 27, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M53Z
July 27, 2020
U.S. President Donald Trump gestures during a tour of the Fujifilm Diosynth Biotechnologies' Innovation...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump gestures during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M518
July 27, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M517
July 27, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M50Z
July 27, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
Sort by
Display
Items per page
Page
of 20